Citation: J. Ancona et al., IMPROVING OUTCOMES THROUGH A DEVELOPMENTAL-APPROACH TO NIPPLE FEEDING, Journal of nursing care quality, 12(5), 1998, pp. 1-4
Authors:
SHEKHAWAT PS
GARLAND JS
SHIVPURI C
MICK GJ
SASIDHARAN P
PELZ CJ
MCCORMICK KL
Citation: Ps. Shekhawat et al., NEONATAL CORD-BLOOD LEPTIN - ITS RELATIONSHIP TO BIRTH-WEIGHT, BODY-MASS INDEX, MATERNAL DIABETES, AND STEROIDS, Pediatric research, 43(3), 1998, pp. 338-343
Authors:
GARLAND JS
ALEX CP
MUELLER CD
CISLERKAHILL LA
Citation: Js. Garland et al., LOCAL REACTIONS TO A CHLORHEXIDINE GLUCONATE-IMPREGNATED ANTIMICROBIAL DRESSING IN VERY-LOW-BIRTH-WEIGHT INFANTS, The Pediatric infectious disease journal, 15(10), 1996, pp. 912-914
Authors:
PEARSON ML
FARR BM
GARLAND JS
MERMEL LA
RAAD II
SHERETZ RJ
STOVER BH
Citation: Ml. Pearson et al., GUIDELINE FOR PREVENTION OF INTRAVASCULAR DEVICE-RELATED INFECTIONS .1. INTRAVASCULAR DEVICE-RELATED INFECTIONS - AN OVERVIEW, American journal of infection control, 24(4), 1996, pp. 262-293
Citation: Js. Garland et al., ACCURACY OF A BEDSIDE LABORATORY ANALYZER (BLA) FOR DETERMINATION OF BLOOD HEMATOCRIT AND CHEMISTRIES IN NEONATES, Pediatric research, 39(4), 1996, pp. 1239-1239
Citation: Js. Garland et al., HYPOCAPNIA BEFORE SURFACTANT THERAPY APPEARS TO INCREASE BRONCHOPULMONARY DYSPLASIA RISK IN INFANTS WITH RESPIRATORY-DISTRESS SYNDROME, Archives of pediatrics & adolescent medicine, 149(6), 1995, pp. 617-622
Authors:
GARLAND JS
BUCK RK
MALONEY P
DURKIN DM
TOTHLLOYD S
DUFFY M
SZOCIK P
MCAULIFFE TL
GOLDMANN D
Citation: Js. Garland et al., COMPARISON OF 10-PERCENT POVIDONE-IODINE AND 0.5-PERCENT CHLORHEXIDINE GLUCONATE FOR THE PREVENTION OF PERIPHERAL INTRAVENOUS CATHETER COLONIZATION IN NEONATES - A PROSPECTIVE TRIAL, The Pediatric infectious disease journal, 14(6), 1995, pp. 510-516
Citation: Js. Garland, DEVELOPMENTAL CARE FOR VERY-LOW-BIRTH-WEIGHT INFANTS, JAMA, the journal of the American Medical Association, 273(20), 1995, pp. 1575-1575
Citation: Js. Garland et Rk. Buck, ASSESSING BRONCHOPULMONARY DYSPLASIA (BPD) RISK WITHIN 24 HOURS OF SURFACTANT THERAPY FOR AN EARLY INTERVENTION TRIAL, Pediatric research, 37(4), 1995, pp. 257-257
Citation: Js. Garland et C. Alex, SURFACTANT THERAPY APPEARS TO DECREASE RESPIRATORY MORBIDITY MORTALITY IN NEONATES BORN TO MOTHERS WHOSE MEMBRANES RUPTURE (ROM) PRIOR TO 24 WEEKS GESTATIONAL-AGE (GA), Pediatric research, 37(4), 1995, pp. 257-257
Citation: Js. Garland et al., EFFECT OF MATERNAL GLUCOCORTICOID EXPOSURE ON RISK OF SEVERE INTRAVENTRICULAR HEMORRHAGE IN SURFACTANT-TREATED PRETERM INFANTS, The Journal of pediatrics, 126(2), 1995, pp. 272-279
Citation: Js. Garland et al., TREATMENT OF INFANTS WITH INDIRECT HYPERBILIRUBINEMIA - READMISSION TO BIRTH HOSPITAL VS NONBIRTH HOSPITAL, Archives of pediatrics & adolescent medicine, 148(12), 1994, pp. 1317-1321
Citation: Js. Garland et al., PROSPECTIVE TRIAL OF POVIDONE-IODINE (PI) VERSUS CHLORHEXIDINE GLUCONATE (C) FOR PREVENTION OF LOCAL PERIPHERAL INTRAVENOUS CATHETER INFECTIONS (LCI) IN NEONATES, Pediatric research, 35(4), 1994, pp. 10000226-10000226
Citation: Js. Garland et al., LOW ARTERIAL PCO2 PRIOR TO ARTIFICIAL SURFACTANT THERAPY (AST) APPEARS TO BE ASSOCIATED WITH BRONCHOPULMONARY DYSPLASIA (BPD) IN INFANTS WITH RESPIRATORY-DISTRESS SYNDROME (RDS), Pediatric research, 35(4), 1994, pp. 10000270-10000270